April 1987

Management of the Urinary Tract Involved by Recurrent Cancer

Author Affiliations

From the Departments of Surgery, New England Deaconess Hospital (Drs Eyre, Benotti, Bothe, Cady, and Steele) and Faulkner Hospital (Dr Eyre), Harvard Medical School, Boston.

Arch Surg. 1987;122(4):493-498. doi:10.1001/archsurg.1987.01400160119018

• We present our experience from 1982 to the present in treating 33 patients with recurrent cancers (colorectal, 22; gynecologic, six; breast, two; melanoma, two; and lung, one) secondarily involving the genitourinary tract. All patients had severe symptoms that required palliation. Endoscopically placed stents relieved ureteral obstruction in 18 (75%) of 24 patients with widespread metastatic disease. Two patients required percutaneous nephrostomy tubes, and five required open operations. Good to excellent palliation was achieved in 23 of 24 patients. Mean survival in the group with diffuse metastases was 13 months (range, six to 29 months). Nine patients with localized recurrences underwent surgical procedures. For localized pelvic recurrences, total exenteration (with or without intraoperative radiotherapy) provided excellent palliation with low morbidity. At the time of this report, five of six such patients had no evidence of disease, and one had a small asymptomatic pelvic recurrence, with a mean follow-up of 13 months (range, five to 19 months).

(Arch Surg 1987;122:493-498)